The Daily Expose elaborated on this claim, citing an October 2022 lecture by Dr. Pieter Cullis delivered at the University of Manitoba in Canada. In the lecture, Cullis was asked if his LNP delivery system is able to target specific tissues or restrict which tissues it stays in.
"That's going to be tricky," he responded. "People have been trying to target these lipids, or any nanomedicine, without any success over 40 years of trying."
According to the Expose, Cullis "is widely credited with inventing the LNP delivery system that ensures the mRNA doesn't degrade before it reaches [the] cells. Without the LNPs, the mRNA would get destroyed long before it got anywhere near a cell and so is critical for the vaccines to "work.'" The Canadian biochemist is also the founder of British Columbia-based Acuitas Therapeutics, which develops LNPs for vaccines – including the mRNA COVID-19 injection from Pfizer and BioNTech.
"They've known for over 40 years that the LNPs wouldn't stay in your arm. In fact, they didn't ever want them to. They wanted the 'vaccine' to travel all [around] your body, so that some of it would find its way to your lymph nodes. There, the dendritic cells were more likely to translate the mRNA as intended," wrote the Naked Emperor on Substack.
"But they kept this quiet from you, because would you really go and get injected if you were told that this new technology would travel all round your body where it would be taken up by all types of cells – including spleen, liver, and ovary cells – which would then be instructed to produce a spike protein created in a lab somewhere, causing who knows what side effects because the trials were cancelled early because it just wasn't fair that the placebo group hadn’t been given mRNA?"...<<<Read More>>>...
